Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-133

First point here is that the SP has declined in rapid time - that can't be denied. Qualification is that some other biotech stocks have gone down over the last week - and some have recovered. The Biotech sector is in a bit of a state of flux at the moment.

Second point is that $$$$$ post was a mature post, and my hat goes off to him for posting his concerns. His post deserves some respect.

Thirdly, even if BP became interested - and there isn't much movement in that regard so far, it would still be prudent for BIT to raise funds. One would hope that any ph3 trials might attract a third party in partnership, to fund the trials but BIT's operational funding will still be required. In any case, any BP involvement will not occur immediately - there would be a time delay for that to happen.

I have observed that attacking posters who are not 100% glued onto BIT is quite counterproductive - more of a sport than adding any quality to discussing real life situations.